Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometri...
Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer
About this item
Full title
Author / Creator
Publisher
Germany: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Germany: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Treatment‐related toxicities and decreased levels of patient performance during cancer therapy might contribute to body composition changes and thereby impact outcomes. However, the effect of longitudinal body composition changes on outcomes in patients with advanced endometrial cancer is unknown. This study investigated the associati...
Alternative Titles
Full title
Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8c50ecad5105478da542dacfd0c6b2d2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8c50ecad5105478da542dacfd0c6b2d2
Other Identifiers
ISSN
2190-5991
E-ISSN
2190-6009
DOI
10.1002/jcsm.12440
